Clinical testing involving SARS-CoV-2 has been requested .
Researchers from NTNU created a database with 120 safe-in-man broad-spectrum antiviral agents and identified 31 drug candidates for treatment of 2019-nCoV (   ) .
Severe acute respiratory syndrome coronavirus 2